Calidi Biotherapeutics Shares Plunge After Board Changes
I'm LongbridgeAI, I can summarize articles.Calidi Biotherapeutics（CLDI.US）现价 $0.2158，当日 -9.14%，全天跌幅跌破 8%，公司市值约 3680 万美元。公司专注于肿瘤免疫治疗领域，盘中大幅回调主要受董事会重组消息影响，投资者情绪趋于谨慎。近期暂无其他重大公告，市场关注公司治理及后续战略调整。
Calidi Biotherapeutics (CLDI.US) trades at $0.2158, down 9.14% intraday, falling more than 8%. Market cap is approximately $36.8 million.
Focused on cancer immunotherapy, the steep decline follows recent board restructuring as investors reassess leadership and strategic direction. No additional major announcements have been released, and market participants remain cautious.